S
PCVX icon

SignatureFD’s Vaxcyte PCVX Stock Holding History

SignatureFD’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378K Sell
6,510
-610
-9% -$33.1K 0.01% 775
2026
Q1 		$414K Buy
7,120
+953
+15% +$51.7K 0.01% 684
2025
Q4 		$285K Buy
6,167
+1,028
+20% +$46K ﹤0.01% 807
2025
Q3 		$185K Buy
5,139
+1,873
+57% +$62.1K ﹤0.01% 1000
2025
Q2 		$106K Buy
3,266
+2,312
+242% +$75.8K ﹤0.01% 1207
2025
Q1 		$36K Sell
954
-14
-1% -$1.12K ﹤0.01% 1754
2024
Q4 		$79.2K Sell
968
-80
-8% -$7.94K ﹤0.01% 1349
2024
Q3 		$120K Buy
1,048
+358
+52% +$32.3K ﹤0.01% 1136
2024
Q2 		$52.1K Sell
690
-77
-10% -$5.24K ﹤0.01% 1493
2024
Q1 		$52.4K Buy
767
+358
+88% +$24.8K ﹤0.01% 1526
2023
Q4 		$25.7K Buy
409
+60
+17% +$3.12K ﹤0.01% 1800
2023
Q3 		$17.8K Buy
349
+105
+43% +$5.18K ﹤0.01% 1904
2023
Q2 		$12.2K Buy
244
+43
+21% +$2.04K ﹤0.01% 2150
2023
Q1 		$7.53K Buy
201
+5
+3% +$212 ﹤0.01% 2336
2022
Q4 		$9.4K Buy
196
+28
+17% +$1.1K ﹤0.01% 2185
2022
Q3 		$4K Buy
168
+109
+185% +$2.76K ﹤0.01% 2550
2022
Q2 		$1K Buy
+59
New +$1.36K ﹤0.01% 2978
2022
Q1 		– Sell
-9
Closed – – 3278
2021
Q4 		$0 Buy
+9
New +$209 ﹤0.01% 3224

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SignatureFD's PCVX Position: Q2 2026 in Review

SignatureFD reduced its Vaxcyte (PCVX) stake by 8.6% in Q2 2026, selling an estimated $33.1K and leaving 6,510 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #775.

SignatureFD first reported a position in PCVX in Q4 2021 and has held it in 18 quarters since. The position peaked at $414K in Q1 2026. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • SignatureFD held 6,510 shares of Vaxcyte worth $378K as of Q2 2026.
  • SignatureFD sold 610 Vaxcyte shares in Q2 2026, an estimated $33.1K.
  • Vaxcyte made up 0.01% of SignatureFD's portfolio in Q2 2026, its #775 holding.
  • SignatureFD first reported a position in Vaxcyte in Q4 2021 and has held it in 18 quarters since.
  • SignatureFD's Vaxcyte position peaked at $414K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.